Explore MyBioSource's premium PCR kits for disease detection and genetic research, offering fast, accurate results for oncology, infectious diseases, and more.
Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test ...
Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its ...
Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration ...
GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...
Columbus Firefighter Richard Barfield Jr. is being honored after rescuing two children and a 4-month-old from a crash, ...
A fully loaded 2026 Buick Envista Avenir, with every major option and accessory, still presents a cheaper alternative to the ...
The "Veterinary Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Technology, Product, Animal Type, Infection Type, End user, Country, and Region - Analysis and Forecast ...
A 2022 study estimates that at-home flu tests have a sensitivity of about 63% if the test is performed within 72 hours of ...
GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback